Insider · CIK 0001563623

Gengos Andrew

Reports to the SEC for 7 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001563623

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-16	IMRXImmuneering Corp · Stock OptionA Award	Chief Financial Officer	AAward	+650K sh	—	—	650,000
2026-06-04	TTRXTurn Therapeutics Inc. · Stock option (right to buy)A Award	Director	AAward	+95K sh	—	—	95,000
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−138K sh	—	—	0
2026-05-05	TERNTerns Pharmaceuticals, Inc.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−40.5K sh	$53.00	−$2.15M	0
2026-05-05	TERNTerns Pharmaceuticals, Inc.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−68.8K sh	$53.00	−$3.64M	0
2026-05-05	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−750K sh	—	—	0
2026-01-14	TERNTerns Pharmaceuticals, Inc.A Award	Chief Financial Officer	AAward	+68.8K sh	—	—	101,788
2026-01-14	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+138K sh	—	—	137,500
2025-10-08	TTRXTurn Therapeutics Inc.A Award	Director	AAward	+10K sh	—	—	10,000
2025-06-27	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.93	+$19.6K	25,000
2025-06-27	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.93	+$19.6K	20,000
2025-06-16	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.95	+$19.7K	15,000
2025-06-13	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.75	+$18.8K	5,000
2025-06-13	TERNTerns Pharmaceuticals, Inc.P Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$3.72	+$18.6K	10,000
2025-02-24	TERNTerns Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+750K sh	—	—	750,000
2024-09-05	LONALeonaBio, Inc.S Sale	CFO and Chief Business Officer	SSale	−1,272 sh	$0.57	−$719.952	97,532
2024-09-03	LONALeonaBio, Inc.A Award	CFO and Chief Business Officer	AAward	+5,000 sh	—	—	98,804
2024-05-20	LONALeonaBio, Inc.A Award	CFO and Chief Business Officer	AAward	+10K sh	$1.34	+$13.4K	93,804
2024-02-14	LONALeonaBio, Inc. · Stock Option (Right to Buy)A Award	CFO and Chief Business Officer	AAward	+280K sh	—	—	280,000
2024-01-05	LONALeonaBio, Inc.S Sale	CFO and Chief Business Officer	SSale	−1,208 sh	$2.91	−$3,515.28	83,804
2024-01-04	LONALeonaBio, Inc.A Award	CFO and Chief Business Officer	AAward	+5,000 sh	—	—	85,012
2023-06-07	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+2,859 sh	$3.40	+$9,720.6	68,293
2023-06-07	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+422 sh	$3.36	+$1,416.907	65,434
2023-06-07	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+11.7K sh	$3.44	+$40.3K	80,012
2023-06-05	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+15K sh	$3.00	+$45K	35,012
2023-06-05	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+10K sh	$3.00	+$30K	45,012
2023-06-05	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+10K sh	$3.00	+$30K	55,012
2023-06-05	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+10K sh	$3.02	+$30.2K	65,012
2023-06-02	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+3,418 sh	$2.94	+$10.1K	20,012
2023-06-02	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+10K sh	$2.75	+$27.5K	10,012
2023-06-02	LONALeonaBio, Inc.P Purchase	CFO and Chief Business Officer	PPurchase	+6,582 sh	$2.86	+$18.8K	16,594
2023-05-18	LONALeonaBio, Inc. · Stock Options (right to buy)A Award	CFO and Chief Business Officer	AAward	+400K sh	—	—	400,000
2023-01-05	LONALeonaBio, Inc.S Sale	CFO and Chief Business Officer	SSale	−1,208 sh	$2.91	−$3,515.28	83,804
2023-01-04	LONALeonaBio, Inc.A Award	CFO and Chief Business Officer	AAward	+5,000 sh	—	—	85,012
2022-02-22	Cyteir Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Business Officer	AAward	+35K sh	—	—	35,000
2018-03-14	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+10K sh	—	—	10,000
2017-10-31	SYBXSYNLOGIC, INC. · Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+154K sh	—	—	154,000
2016-12-31	IMUCEOM Pharmaceutical Holdings, Inc.F Tax Payment	Director	FTax Payment	−3,284 sh	$2.05	−$6,732.2	5,249
2016-03-11	IMUCEOM Pharmaceutical Holdings, Inc.A Award	Director	AAward	+150K sh	—	—	341,333
2016-03-11	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+350K sh	—	—	350,000
2015-11-30	IMUCEOM Pharmaceutical Holdings, Inc.P Purchase	Director	PPurchase	+10K sh	$0.43	+$4,350	47,000
2015-03-20	IMUCEOM Pharmaceutical Holdings, Inc.A Award	Director	AAward	+150K sh	—	—	228,333
2015-03-20	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (Rt to Buy)A Award	Director	AAward	+175K sh	—	—	175,000
2015-03-20	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (Rt to Buy)A Award	Director	AAward	+175K sh	—	—	175,000
2015-02-18	IMUCEOM Pharmaceutical Holdings, Inc. · Warrant to Purchase Common StockP Purchase	Director	PPurchase	+28.9K sh	—	—	28,933
2015-02-18	IMUCEOM Pharmaceutical Holdings, Inc.P Purchase	Director	PPurchase	+41.3K sh	$0.60	+$24.8K	78,333
2014-08-14	IMUCEOM Pharmaceutical Holdings, Inc.P Purchase	Director	PPurchase	+10K sh	$0.90	+$8,994	37,000
2014-03-07	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+200K sh	—	—	200,000
2013-12-18	IMUCEOM Pharmaceutical Holdings, Inc.P Purchase	Director	PPurchase	+27K sh	$0.72	+$19.4K	27,000
2012-12-03	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	−700K sh	—	—	700,000

Recent filings

Accepted (ET)
Jul 174
Gengos Andrew0001790340-26-000082
SEC(opens sec.gov)
Jun 84
Gengos Andrew0001213900-26-066394
SEC(opens sec.gov)
May 54
Gengos Andrew0001563623-26-000004
SEC(opens sec.gov)
Jan 164
Gengos Andrew0001563623-26-000002
SEC(opens sec.gov)
Oct 104
Gengos Andrew0001104659-25-098567
SEC(opens sec.gov)
Jun 304
Gengos Andrew0001562180-25-005120
SEC(opens sec.gov)
Jun 164
Gengos Andrew0001562180-25-004866
SEC(opens sec.gov)
Feb 254
Gengos Andrew0001562180-25-001632
SEC(opens sec.gov)
Sep 54
Gengos Andrew0001415889-24-022987
SEC(opens sec.gov)
Feb 164/A
Gengos Andrew0001415889-24-004149
SEC(opens sec.gov)
Feb 164
Gengos Andrew0001415889-24-004158
SEC(opens sec.gov)

Companies

Address

245 MAIN STREET SECOND FLOOR

CAMBRIDGE, MA, 02142